An in vitro system combined with an in-house quantitation assay for screening hepatitis C virus inhibitors

Antiviral Research

Volumn 58, Issue 3, 2003, Pages 199-208

  Ho, Tin Yun ^a   Wu, Shih Lu ^a   Lai, I Lu ^a   Cheng, Ken Sheng ^b   Kao, Shung Te ^a   Hsiang, Chien Yun ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Centrifugation facilitated inoculation; Chinese medicinal herbs; Hepatitis C virus; Nested competitive reverse transcription polymerase chain reaction

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; ARNEBIA EUCHROMA EXTRACT; PLANT EXTRACT; PONCIRUS TRIFOLIATA EXTRACT; THLASPI ARVENSE EXTRACT; UNCLASSIFIED DRUG; VIRUS RNA;

ANALYZER; ANIMAL CELL; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARNEBIA EUCHROMA; ARTICLE; CELL CULTURE; CENTRIFUGATION; CYTOTOXICITY; DISEASE MODEL; DNA STRAND; DRUG SCREENING; FANWEED; HEPATITIS C VIRUS; HUMAN; INOCULATION; MEDICINAL PLANT; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIFOLIATE ORANGE; VERO CELL; VIRUS INFECTION;

ARNEBIA; ARNEBIA EUCHROMA; HEPATITIS C VIRUS; PONCIRUS TRIFOLIATA; THLASPI ARVENSE;

EID: 0038397416     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(03)00004-4     Document Type: Article

References (44)

1. Alter M.J., Margolis H.S., Krawczynski K., Judson F.N., Mares A., Alexander W.J., Hu P.Y., Miller J.K., Gerber M.A., Sampliner R.E. The natural history of community acquired hepatitis C in the United States. New Engl. J. Med. 327:1992;1899-1905.
2. Blight K.J., Kolykhalov A.A., Rice C.M. Efficient initiation of HCV RNA replication in cell culture. Science. 290:2000;196-198.
3. Brumback B.G., Wade C.D. Simultaneous culture for adenovirus, cytomegalovirus, and herpes simplex virus in same shell vial by using three-color fluorescence. J. Clin. Microbiol. 32:1994;2289-2290.
4. Chomczynski P., Sacchi N. Single-step method for RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
5. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone derived from a blood-born non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
6. Chu C.M., Lin S.M., Hsieh S.Y., Yeh C.T., Lin D.Y., Sheen I.S., Liaw Y.F. Etiology of sporadic acute viral hepatitis in Taiwan: the role of hepatitis C virus, hepatitis E virus and GB virus-C/hepatitis G virus in an endemic area of hepatitis A and B. J. Med. Virol. 58:1999;154-159.
7. Cribier B., Schmitt C., Bingen A., Kirn A., Keller F. In vitro infection of peripheral blood mononuclear cells by hepatitis C virus. J. Gen. Virol. 76:1995;2485-2491.
8. Crotty S., Maag D., Arnold J.J., Zhong W., Lau J.Y., Hong Z., Andino R., Cameron C.E. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nat. Med. 6:2000;1375-1379.
9. Damen M., Sillekens P., Cuypers H.T.M., Frantzen I., Melsert R. Characterization of the quantitative HCV NASBA assay. J. Virol. Methods. 82:1999;45-54.
10. Haberhausen G., Pinsl J., Kuhn C.C., Markert-Hahn C. Comparative study of different standardization concepts in quantitative competitive reverse transcription-PCR assays. J. Clin. Microbiol. 36:1998;628-633.
11. Hoofnagle J., Lau D. Chronic viral hepatitis-benefits of current therapies. New Engl. J. Med. 44:1996;1470-1471.
12. Ikeda M., Sugiyama K., Mizutani T., Tanaka T., Tanaka K., Sekihara H., Shimotohno K., Kato N. Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus. Virus Res. 56:1998;157-167.
13. Ito T., Mukaigawa J., Zuo J., Hirabayashi Y., Mitamura K., Yasui K. Cultivation of hepatitis C virus in primary hepatocyte culture from patients with chronic hepatitis C results in release of high titer infectious virus. J. Gen. Virol. 77:1996;1043-1054.
14. Kishimoto H., Yoshioka K., Yano M., Ukai K., Ito H., Watanabe K., Kawamata O., Kakumu S. Real-time detection system for quantitation of hepatitis C virus RNA: a comparison with the other three methods. Hepatol. Res. 19:2001;12-21.
15. Klespies S.L., Cebula D.E., Kelly C.L., Galehouse D., Maurer C.C. Detection of enteroviruses from clinical specimens by spin amplification shell vial culture and monoclonal antibody assay. J. Clin. Microbiol. 34:1996;1465-1467.
16. Kolberg, J.A., Sanchez-Pescador, R., Detmer, J., Collins, M., Sheridan, P., Neuwald, P., Wilber, J., 1994. Branched DNA quantitation of hepatitis C viral RNA in patients sera. In: Group Francais d'Etudes Moleculaires des hepatites virales (GEMHEP) (Ed.), Hepatitis C Virus: New Diagnostic Tool. Jone Libbey Eurotext, Paris, pp. 57-70.
17. Lanford R.E., Sureau C., Jacob J.R., White R., Fuerst T.R. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT-PCR. Virology. 202:1994;607-614.
18. Lee J.H., von Wagner M., Roth W.K., Teuber G., Sarrazin C., Zeuzem S. Effect of ribavirin on virus load and quasispecies distribution in patients infected with hepatitis C virus. J. Hepatol. 29:1998;29-35.
19. Leyssen P., de clercq E., Neyts J. Perspectives for the treatment of infection with Flaviviridae. Clin. Microbiol. Rev. 13:2000;67-82.
20. Liu J., Shen H.M., Ong C.N. Salvia miltiorrhiza inhibits cell growth and induces apoptosis in human hepatoma HepG2 cells. Cancer Lett. 153:2000;85-93.
21. Maag D., Castro C., Hong Z., Cameron C.E. Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin. J. Biol. Chem. 276:2001;46094-46098.
22. Manzin A., Bagnarelli P., Menzo S., Giostra F., Brugia M., Francesconi R., Bianchi F.B., Clementi M. Quantitation of hepatitis C virus genome molecules in plasma samples. J. Clin. Microbiol. 32:1994;1939-1944.
23. Martell M., Gomez J., Esteban J.I., Sauleda S., Quer J., Cabot B., Esteban R., Guardia J. High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA. J. Clin. Microbiol. 37:1999;327-332.
24. Martinot Peignoux M., Boyer N., Pouteau M., Castelnau C., Giuily N., Duchatelle V., Auperin A., Degott C., Benhamou J.P., Erlinger S., Marcellin P. Predictors of sustained response to alpha interferon therapy in chronic hepatitis C. J. Hepatol. 29:1998;214-223.
25. Matsuda H., Murakami T., Ninomiya K., Inadzuki M., Yoshikawa M. New hepatoprotective saponins, bupleurosides III, VI, IX, and XIII, from Chinese Bupleuri Radix: structure-requirements for the cytoprotective activity in primary cultured rat hepatocytes. Bioorg. Med. Chem. Lett. 7:1997;2193-2198.
26. McHutchison J.G., Gordon S.C., Schiff E.R., Shiffman M.L., Lee W.M., Rustgi V.K., Goodman Z.D., Ling M.H., Cort S., Albrecht J.K. Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. New Engl. J. Med. 339:1998;1485-1492.
27. Miskovsky E., Carrella A., Gutekunst K., Sun C., Quinn T., Thomas D. Clinical characterization of a competitive PCR assay for quantitative testing of hepatitis C virus. J. Clin. Microbiol. 34:1996;1975-1979.
28. Morrica A., Giorgi M., Maggi F., Fornai C., Vatteroni M.L., Marchi S., Richiuti A., Antonelli G., Pistello M., Bendinelli M. Susceptibility of human and non-human cell lines to HCV infection as determined by the centrifugation-facilitated method. J. Virol. Methods. 77:1999;207-215.
29. Nozaki A., Kato N. Quantitative method of intracellular hepatitis C virus RNA using LightCycler PCR. Acta Med. Okayama. 56:2002;107-110.
30. Rosen H.R., Gretch D.R. Hepatitis C virus: current understanding and prospects for future therapies. Mol. Med. Today. 5:1999;393-399.
31. Sato H., Goto W., Yamamura J., Kurokawa M., Kageyama S., Takahara T., Watanabe A., Shiraki K. Therapeutic basis of glycyrrhizin on chronic hepatitis B. Antiviral Res. 30:1996;171-177.
32. Seipp S., Mueller H.M., Pfaff E., Stremmel W., Theilmann L., Goeser T. Establishment of persistent hepatitis C virus infection and replication in vitro. J. Gen. Virol. 78:1997;2467-2476.
33. Sherman A. HCV on the threshold. Infect. Med. 16:1999;92-94.
34. Sheu J.C., Wang J.T., Wang T.H., Wang C.Y., Yang P.M., Huang G.T., Shih L.N., Lee H.S., Chen D.S. Prevalence of hepatitis C viral infection in a community in Taiwan. Detection by synthetic peptide-based assay and polymerase chain reaction. J. Hepatol. 17:1993;192-198.
35. Shiratori Y., Kato N., Yokosuka O., Imazeki F., Hashimoto E., Hayashi N., Nakamura A., Asada M., Kuroda H., Tanaka N., Arakawa Y., Omata M. Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Gastroenterology. 113:1997;558-566.
36. Song Z.Q., Hao F., Min F., Ma Q.Y., Liu G.D. Hepatitis C virus infection of human hepatoma cell line 7721 in vitro. World J. Gastroenterol. 7:2001;685-689.
37. Tagawa M., Kato N., Yokosuka O., Ishikawa T., Ohto M., Omata M. Infection of human hepatocyte cell lines with hepatitis C virus in vitro. J. Gastroenterol. Hepatol. 10:1995;523-527.
38. Tsuboi S., Nagamori S., Miyazaki M., Mihara K., Fukaya K., Teruya K., Kosaka T., Tsuji T., Namba M. Persistence of hepatitis C virus RNA in established human hepatocellular carcinoma cell lines. J. Med. Virol. 48:1996;133-140.
39. Valli M.B., Carloni G., Manzi A., Nasorri F., Ponzetto A., Clementi M. Hepatitis C virus infection of a Vero cell clone displaying efficient virus-cell binding. Res. Virol. 148:1997;181-186.
40. World Health Organization, 1997. Hepatitis C: global prevalence. Wkly. Epidemiol. Rec. 10, 65-72.
41. Yoshikawa M., Murakami T., Hirano K., Inadzuki M., Ninomiya K., Matsuda H. Scorzonegosides A, B, and C, novel triterpene oligoglycosides with hepatoprotective effect from Chinese Bupleuri Radix, the roots of Bupleurum scorzonerifolium WILLD. Tetrahedron Lett. 38:1997;7395-7398.
42. Zibert A., Schreier E., Roggendorf M. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology. 208:1995;653-661.
43. Ziegler T., Hall H., Sanchez-Fauquier A., Gamble W.C., Cox N.J. Type- and subtype-specific detection of influenza viruses in clinical specimens by rapid culture assay. J. Clin. Microbiol. 33:1995;318-321.
44. Zoulim F., Haem J., Ahmed S.S., Chossegros P., Habersetzer F., Chevallier M., Bailly F., Trepo C. Ribavirin monotherapy in patients with chronic hepatitis C: a retrospective study of 95 patients. J. Viral Hepat. 5:1998;193-198.